California Lawsuit over AI Use in Medical Visits Raises Privacy Concerns
A legal action in California raises privacy concerns over the use of AI transcription tools during medical visits.
A group of Californian residents recently filed a lawsuit against Sutter Health and MemorialCare, alleging the unauthorized use of an artificial intelligence (AI)-based transcription tool during medical visits. The case raises significant questions about how patient privacy is managed and about the use of emerging technologies in healthcare.
Details of the Lawsuit
The suit, brought as a class action, was filed in a federal court in San Francisco. The plaintiffs say they received medical care at several Sutter Health and MemorialCare facilities over the past six months. During these visits, medical staff allegedly used Abridge AI, a system that captures, transcribes and summarizes conversations between patients and doctors, turning them into clinical notes. According to the complaint, patients were not clearly informed that their medical communications would be recorded by an artificial intelligence platform, transmitted outside the clinical environment or processed by third-party systems. The recordings contained identifiable medical information, including clinical histories, symptoms, diagnoses, medications and treatment discussions.
Implications for Patient Privacy
This case highlights the emerging challenges in protecting patient privacy in an era of growing digitization and use of AI in healthcare. Transparency about technologies such as Abridge AI is essential to ensure that patients are aware of how their health information is collected, used and shared. Failing to provide adequate information can undermine patients' trust in the healthcare system and raise legal concerns about compliance with privacy regulations.
Responses from the Parties Involved
In response to the lawsuit, Sutter Health said it is aware of the situation and takes patient privacy seriously, and is committed to protecting the security of patient information. It stressed that the technology used in clinical settings is evaluated and implemented in compliance with applicable laws and regulations. MemorialCare, for its part, chose not to comment on the ongoing case. Abridge AI, valued at $5.3 billion in June 2025, did not immediately respond to requests for comment.
Similar Legal Precedents
This is not the first time the use of AI transcription tools has raised legal concerns. For example, in 2025, Otter.ai was accused of recording private conversations without the consent of all participants and using the recordings to train its speech recognition and machine learning systems. Moreover, in 2026, Perplexity AI was accused of secretly sharing user conversation data with Google and Meta for advertising purposes, violating California privacy laws.
Considerations for the Future
The growing use of AI in healthcare calls for a balance between technological innovation and protecting patients' rights. It is essential that healthcare organizations implement technologies transparently, obtaining patients' informed consent and ensuring compliance with privacy regulations. In addition, it is crucial that patients are educated about the use of technology during their medical visits, so that their sensitive information is handled with the utmost respect and confidentiality.
- Transparency in the use of technology: Healthcare organizations must clearly inform patients about the use of AI tools during medical visits, obtaining their explicit consent.
- Compliance with privacy regulations: It is essential that the technologies deployed comply with the laws and regulations governing the protection of patients' personal data.
- Patient education: Patients should be educated about the use of technology during their medical visits, to ensure their sensitive information is handled with the utmost respect and confidentiality.
- Monitoring and auditing: Healthcare organizations should implement monitoring and audit systems to ensure technologies are used appropriately and in line with internal policies and external regulations.
- Responding to legal concerns: Organizations must be ready to respond appropriately to any legal concern raised about the use of technology, ensuring patient rights are protected and applicable laws are complied with.